Ashley Gallagher

2 days ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

This interview was recorded on June 4, 2025, at 11:00 am. Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy, particularly focusing on the complex challenges surrounding vaccine access, recommendations, and public perception.

3 days ago | drugtopics.com | Ashley Gallagher

Simvastatin did not show additional antidepressive effects when added to escitalopram for patients who have obesity and major depressive disorder, according to results of a study published in JAMA Psychiatry.

3 days ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

This interview was recorded on June 4, 2025, at 11:00 am. The 2025-2026 COVID-19 vaccine formulation is set to remain monovalent, targeting the JN.1 lineage of the SARS-CoV-2 virus, with a preference for the LP8.1 strain.

3 days ago | drugtopics.com | Ashley Gallagher

Microvascular complications due to type 2 diabetes (T2D) contribute to cognitive impairment and depression, according to results of a study published in Diabetology and Metabolic Syndrome.

4 days ago | drugtopics.com | Ashley Gallagher

Some social determinants of health (SDOH) were associated with hormone therapy use for the treatment of menopause, indicating that more favorable SDOH may be associated with better access to care, according to results of a study published in Biology of Sex Differences.